Create a narrative

Addex Therapeutics Community

SWX:ADXN Community

1 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

Addex Therapeutics

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

CNS And Respiratory Therapies Will Unlock Expanding Global Markets

Key Takeaways Differentiated CNS and respiratory pipeline, positive clinical progress, and strategic partnerships position Addex for long-term growth with stabilized earnings and mitigated R&D risk. Expanded intellectual property and global market trends enhance future out-licensing opportunities and scalability potential for Addex's novel therapies.

CHF 0.16

FV

65.1% undervalued

108.83%

Revenue growth p.a.

0

0

0

about 8 hours ago